Q&A SESSION — Post-Market Drug Evaluation Program Call for Standing Offer Contractors

Event date: Thursday, May 5, 2022
Time: 1:00 p.m. to 1:30 p.m. EDT
Zoom webinar (free — registration required)

Register

In February 2022, CADTH announced the creation of a Post-Market Drug Evaluation (PMDE) Program. 

The PMDE Program is responsible for establishing and coordinating a network of experts in applied drug research, methodology, and data analysis who can deliver timely evidence in response to policy questions about the post-market safety and effectiveness of drugs approved in Canada. To establish a solid network that is responsive and dynamic, funding will be allocated to network partners through both grants (65%) and contracts (35%).

On February 1, 2022, the PMDE Program launched its Request for Proposal (RFP) for Core Network Partner grants, and on March 15, 2022, a second RFP was issued for Standing Offer Contractors.

For an opportunity to ask questions and hear answers about the RFP process for Standing Offer Contractors, plan to attend CADTH’s 30-minute PMDE Program information session. You’ll have the opportunity to: 

• learn about the new PMDE Program and its pan-Canadian query response network
• understand how to respond to the RFP for contract funding
• ask questions through a live question and answer forum.

There is no cost to attend but registration is required. After registering, you will receive a confirmation email with information about how to join the webinar.
 
Presenters:

Dr. Tarry Ahuja, Director, PMDE Program
Nadine Sulatycky, PMDE Program Lead

Related information:

• PMDE Program website
• PMDE Program Overview
• Information Session — Post-Market Drug Evaluation Program Call for Standing Offer Contractors
• Introducing CADTH’s New Post-Market Drug Evaluation Program (February 8 webinar recording)
• Subscribe to our eAlerts to receive future PMDE Program updates from CADTH